The Motley Fool

Key Data Points

Primary metrics and data points about Keryx Biopharmaceuticals.
Current Price: $10.34
Prev Close: $10.29
Open: $10.33
Bid: $10.34
Ask: $10.35
Day's Range: $10.15 - $10.47
52wk Range: $8.84 - $18.48
Volume: 488,181
Avg Vol 2,043,225
Market Cap: $1B
P/E (ttm): -7.57
EPS (ttm): ($1.36)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Keryx Biopharmaceuticals.

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

KERX vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Keryx Biopharmaceuticals.
CAPS Rating 2 out of 5
 
395 Outperform
65 Underperform
CAPS All Stars
 
60 Outperform
17 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Ron Bentsur, CEO

0% Approve

Based on 0 Ratings

Powered by

More Details about Keryx Biopharmaceuticals

Primary metrics and data points about Keryx Biopharmaceuticals.